NUTCRACKER
LIVE

Serial Number

90203729

Owner

MEDICI THERAPEUTICS, INC.

Attorney

Susan E. Farley

First Use Date

Sep 23, 2020

Filing Date

Sep 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NUTCRACKER Trademark

Serial Number: 90203729 • Registration: 6371974

NUTCRACKER is a trademark filed by MEDICI THERAPEUTICS, INC. on September 23, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MEDICI THERAPEUTICS, INC.

240 LONGWOOD AVENUE, SUITE 125
BOSTON, MA 02115

Entity Type: 03

Nutcracker Therapeutics, Inc. (21 trademarks)

Emeryville, CA 94608

Entity Type: 03

Trademark Details

Filing Date

September 23, 2020

Registration Date

June 1, 2021

First Use Anywhere

September 23, 2020

First Use in Commerce

September 23, 2020

Published for Opposition

March 16, 2021

Goods & Services

Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic sciences; Compiling data for research purposes in the field of medical science and medical consultancy; DNA analysis services for scientific research purposes; Medical and scientific research, in particular in the fields of prevention and treatment cancer; providing scientific research information, consultancy, and advisory services, in particular in the fields of prevention and treatment of cancer treatment; Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; and consulting services for others in the field of design, planning, and implementation of clinical trials; Design, engineering, research, development and testing services in the field of nucleic acid sciences for medical, scientific and technological applications; Scientific research; scientific research in the fields of pharmaceuticals, medicine, biologics, bio therapeutics, biosimilars and therapeutics

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 3, 2026 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 1, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 1, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 16, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2021 NONP
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Feb 12, 2021 AAUA
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2021 CNSA
USE AMENDMENT ACCEPTED
Feb 11, 2021 IUAA
ASSIGNED TO EXAMINER
Feb 10, 2021 DOCK
AMENDMENT TO USE PROCESSING COMPLETE
Dec 29, 2020 AUPC
USE AMENDMENT FILED
Dec 29, 2020 IUAF
TEAS AMENDMENT OF USE RECEIVED
Dec 28, 2020 EAAU
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 4, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 3, 2020 NWOS
NEW APPLICATION ENTERED
Sep 26, 2020 NWAP